3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
136
Motor Activity
72
Fatigue
10
Neoplasms
9
Obesity
8
Lymphedema
8
Colorectal Neoplasms
7
Weight Loss
6
Cardiotoxicity
6
Prostatic Neoplasms
5
Breast Cancer Lymphedema
5
Ovarian Neoplasms
3
Breast Cancer Female
3
Triple Negative Breast Neoplasms
2
Recurrence
2
Overweight
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Lung Neoplasms
2
Insulin Resistance
2
Depression
2
Breast Diseases
2
Breast Cancer Survivors
2
Body Weight Changes
2
Atherosclerosis
2
Arthralgia
2
Ventricular Dysfunction, Left
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urogenital Neoplasms
1
Interventions
Paclitaxel
3
Acupuncture Therapy
3
Glutamine
2
Fatty Acids, Omega-3
2
Cryotherapy
2
eribulin
1
Yoga
1
Vitamin D
1
Vitamin B 6
1
Vitamin B 12
1
Thioctic Acid
1
Taxoids
1
Surveys and Questionnaires
1
Sugars
1
Sodium Chloride
1
Silymarin
1
Saline Solution
1
Physical Therapy Modalities
1
Pentoxifylline
1
Omacor
1
Minocycline
1
Methods
1
Metformin
1
Massage
1
Magnetic Resonance Spectroscopy
1
Losartan
1
Lidocaine
1
Hydroxychloroquine
1
Fumigant 93
1
Fish Oils
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Peripheral Nervous System Diseases
×
Exercise
×
Breast
×
Clear all
NCT02473861
2019-02-19
EXIT
University of British Columbia
Phase NA
Completed
31 enrolled